Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-007999
Filing Date
2025-10-15
Accepted
2025-10-15 16:34:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4595
  Complete submission text file 0001950047-25-007999.txt   6095
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Subject) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38599 | Film No.: 251395230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Jung Cassie (Reporting) CIK: 0001960154 (see all company filings)

Type: 144